Business
OptimizeRx Reports First Quarter 2025 Financial Results and Updates Fiscal Year 2025 Guidance
Q1 revenue of $21.9 million, increasing 11% year-over-yearQ1 gross profit increased 9% year-over-year to $13.3 millionIncreases full year 2025 guidance to a revenue range between $101 million and $106 million and adjusted EBITDA range between $13 million and $15 million WALTHAM, Mass., May 12, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HC
About this update from Optimizerx Corporation
[{"type":"image","alt":"OptimizeRx Corporation","displaySize":"","headline":null,"caption":"OptimizeRx Corporation","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":60,"url":"https://media.zenfs.com/en/globenewswire.com/bafeb18d49fc7337795e7ef66fc70577"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/4Hx5ZcAmkLl71Ls7e9g04A--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTg0O2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/bafeb18d49fc7337795e7ef66fc70577","width":300,"height":60}},"lazy":false},{"type":"list","items":[{"val":[{"type":"text","content":"Q1 revenue of $21.9 million, increasing 11% year-over-year","length":58,"tagName":"p"}]},{"val":[{"type":"text","content":"Q1 gross profit increased 9% year-over-year to $13.3 million","length":65,"tagName":"p"}]},{"val":[{"type":"text","content":"Increases full year 2025 guidance to a revenue range between $101 million and $106 million and adjusted EBITDA range between $13 million and $15 million","length":152,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":275,"olType":false},{"type":"text","content":"WALTHAM, Mass., May 12, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, today reported results for the three months ended March 31, 2025. Quarterly comparisons are to the same year-ago period.","length":372,"tagName":"p"},{"type":"text","content":"Financial Highlights","length":20,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Revenue in the first quarter of 2025 increased 11% to $21.9 million, as compared to $19.7 million in the same year ago period","length":125,"tagName":"p"}]},{"val":[{"type":"text","content":"Gross profit in the first quarter of 2025 increased 9% year-over-year to $13.3 million, from $12.2 million during the first quarter of 2024","length":139,"tagName":"p"}]},{"val":[{"type":"text","content":"GAAP net loss totaled $(2.2) million or $(0.12) per basic and diluted share in the first quarter of 2025, as compared to $(6.9) million or $(0.38) per basic and diluted share during the first quarter of 2024","length":207,"tagName":"p"}]},{"val":[{"type":"text","content":"Non-GAAP net income in the first quarter totaled $1.5 million or $0.08 p...